0.6499
price down icon2.77%   -0.0185
 
loading
Schlusskurs vom Vortag:
$0.6684
Offen:
$0.66
24-Stunden-Volumen:
802.65K
Relative Volume:
0.06
Marktkapitalisierung:
$67.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-225.14M
KGV:
-0.3316
EPS:
-1.96
Netto-Cashflow:
$-192.27M
1W Leistung:
+27.43%
1M Leistung:
-1.49%
6M Leistung:
-33.28%
1J Leistung:
-68.60%
1-Tages-Spanne:
Value
$0.6342
$0.6797
1-Wochen-Bereich:
Value
$0.49
$0.6797
52-Wochen-Spanne:
Value
$0.3546
$2.74

Invivyd Inc Stock (IVVD) Company Profile

Name
Firmenname
Invivyd Inc
Name
Telefon
(781) 819-0080
Name
Adresse
1601 TRAPELO ROAD, WALTHAM
Name
Mitarbeiter
100
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
IVVD's Discussions on Twitter

Vergleichen Sie IVVD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IVVD
Invivyd Inc
0.6499 67.30M 0 -225.14M -192.27M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-05 Hochstufung Guggenheim Neutral → Buy
2024-03-26 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-12-19 Hochstufung Morgan Stanley Underweight → Equal-Weight
2023-05-01 Eingeleitet H.C. Wainwright Buy

Invivyd Inc Aktie (IVVD) Neueste Nachrichten

pulisher
Apr 23, 2025

What is Invivyd Inc (IVVD) Stock Return on Shareholders’ Capital? - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Guggenheim upgrades Invivyd Inc (IVVD) rating to a Buy - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms - Endpoints News

Apr 22, 2025
pulisher
Apr 22, 2025

IVVD Stock Price and Chart — NASDAQ:IVVD - TradingView

Apr 22, 2025
pulisher
Apr 22, 2025

Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Ba - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Invivyd Inc (IVVD) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 22, 2025
pulisher
Apr 21, 2025

Invivyd secures $30 million loan for COVID-19 antibody development By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

What's Going On With Invivyd Stock On Monday? - AOL.com

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Announces $30 Million Loan Facility With Silicon Valley Bank - citybiz

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd (IVVD) Secures $30 Million Loan Facility from Silicon Valley Bank - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd gets $30M term loan facility from Silicon Valley Bank - MSN

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Secures $30 Million Loan from SVB - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Bank | FCNCA Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Enters $30 Mln Term Loan Facility With Silicon Valley Bank - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd secures $30 million loan for COVID-19 antibody development - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd, Inc. Secures $30 Million Term Loan Facility from Silicon Valley Bank to Advance Viral Infectious Disease Pipeline - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Lands Strategic $30M Financing Deal: What This Means for VYD2311's FDA Journey - Stock Titan

Apr 21, 2025
pulisher
Apr 15, 2025

Invivyd - WACH

Apr 15, 2025
pulisher
Apr 09, 2025

Invivyd Inc (NASDAQ: IVVD) – Analysts’ Views Revised To A Positive - stocksregister.com

Apr 09, 2025
pulisher
Apr 03, 2025

Invivyd, Inc. (NASDAQ:IVVD) Sees Large Drop in Short Interest - MarketBeat

Apr 03, 2025
pulisher
Mar 27, 2025

Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Invivyd Appoints Ajay Royan to its Board of Directors - citybiz

Mar 27, 2025
pulisher
Mar 26, 2025

Invivyd adds venture capitalist Ajay Royan to board By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Invivyd Appoints Ajay Royan to Board of Directors - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Invivyd adds venture capitalist Ajay Royan to board - Investing.com India

Mar 26, 2025
pulisher
Mar 23, 2025

Invivyd’s (IVVD) Buy Rating Reiterated at D. Boral Capital - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI - Business Wire

Mar 21, 2025
pulisher
Mar 21, 2025

Invivyd Reports Strong Revenue Growth and Promising Developments - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Invivyd earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 -March 20, 2025 at 08:12 am EDT - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights - The Manila Times

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Reports 48% Q4 Revenue Growth for PEMGARDA™ and Advances Next-Generation Antibody VYD2311 - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Full Year Loss Decreases, But Misses Estimates - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd (IVVD) Projected to Post Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 12, 2025

Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 06, 2025

D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - MarketBeat

Mar 06, 2025
pulisher
Mar 05, 2025

Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1 - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd's COVID Treatment Still Works Against Elusive LP.8.1 VariantCritical News for Immunocompromised Patients - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Invivyd Inc [IVVD] Insider Activity: An Update for Investors - Knox Daily

Mar 04, 2025
pulisher
Mar 04, 2025

Invivyd Inc’s Banking’s 100-Day Moving Average at 0.8392: Will the Stock Break Through? - investchronicle.com

Mar 04, 2025
pulisher
Mar 02, 2025

Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 02, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 26, 2025

D. Boral Capital Reiterates “Buy” Rating for Invivyd (NASDAQ:IVVD) - Armenian Reporter

Feb 26, 2025
pulisher
Feb 25, 2025

The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Invivyd (NASDAQ:IVVD) Receives “Buy” Rating from D. Boral Capital - Defense World

Feb 25, 2025
pulisher
Feb 25, 2025

Invivyd (NASDAQ:IVVD) Given “Buy” Rating at HC Wainwright - Defense World

Feb 25, 2025

Finanzdaten der Invivyd Inc-Aktie (IVVD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Invivyd Inc-Aktie (IVVD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MCGUIRE TERRANCE
Director
Dec 27 '24
Sale
0.52
83,744
43,647
3,256,776
MCGUIRE TERRANCE
Director
Dec 30 '24
Sale
0.48
86,545
41,784
3,170,231
MCGUIRE TERRANCE
Director
Dec 20 '24
Sale
0.42
119,805
50,725
3,568,274
MCGUIRE TERRANCE
Director
Dec 26 '24
Sale
0.54
83,817
45,563
3,340,520
MCGUIRE TERRANCE
Director
Dec 24 '24
Sale
0.51
68,161
34,503
3,424,337
MCGUIRE TERRANCE
Director
Dec 23 '24
Sale
0.45
75,776
34,076
3,492,498
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):